Snehal Patel

Snehal Patel

Chief Executive OfficeratGreenwich LifeSciences· In proxies 2022–2025

Pay in FY2025-4% from the year before · Greenwich LifeSciences stock +87.1% the same year

Snehal Patel was paid $6.0M in FY2025 (Dec), down 4%. Greenwich LifeSciences stock rose 87.1% that year.

Pay$100 in the stock at the end of FY21 → $86
Pay is from the Summary Compensation Table of each Greenwich LifeSciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Greenwich LifeSciencesPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -23%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?